Neurona Therapeutics, USA
Dr. Catherine Priest is the Chief Development Officer at Neurona Therapeutics, a clinical-stage company developing regenerative neural cell therapies. Prior to Neurona, she was at the California Institute for Regenerative Medicine (CIRM), where she managed Translational and Clinical programs. Previously, Dr. Priest led the Preclinical Cellular Therapeutics group at Geron Corporation, managed a research group at Bayer Biotechnology, and was an Assistant Professor at the University of Maryland School of Medicine, where her lab focused on neuroendocrine modulation of behavior and neural circuitry. Dr. Priest received a Bachelor’s degree in Biology and Psychology from Kalamazoo College, and a Ph.D. in Neuroanatomy and Cell Biology from the UCLA School of Medicine. She did postdoctoral training The Rockefeller University and at Mt. Sinai Medical School.
PROGRESSING CELL THERAPIES TO CLINIC: UNDERSTANDING THE CELLULAR DRUG PRODUCT
Friday, July 12, 2024
8:15 AM – 9:45 AM CEST
PLENARY VI: THE CLINICAL REALITY AND PROMISE OF CELL AND GENE THERAPIES
Saturday, July 13, 2024
10:00 AM – 11:35 AM CEST
Saturday, July 13, 2024
10:05 AM – 10:25 AM CEST